FDA Approves First Generic Version of Advair for Asthma, COPD
The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the US FDA.
The first generic form of the Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler has been approved by the US FDA.
Overweight/obese teens, young adults taking supplements do not have improved asthma control.
Odds of being undiagnosed higher for girls, Asian-Americans vs white non-Hispanics.
The combined use of mometasone furoate and formoterol in adults and adolescents with persistent asthma may not increase asthma-related adverse events and may reduce the risk of worsening asthma outcomes.
Clinicians are gaining a better understanding of how asthma and allergies are regulated by the circadian clock, which will help patients better alleviate their symptoms.
Omalizumab rescue therapy produced rapid results in a patient with refractory status asthmaticus.
Bronchoscopic lung volume reduction with valve replacement shows the most promise for improving lung function, exercise tolerance, and quality of life in patients with advanced emphysema.
Gaps in insurance coverage increased the odds of asthma-related emergency department intervention or hospitalization and exacerbations.
Facilitator-led sites had a higher percentage of patients who reported equal participation with their provider in making asthma treatment decisions vs the lunch-and-learn sites.
Adolescents with asthma treated with dupilumab experienced significant improvements in FEV1 compared with placebo.